---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042286"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2026-09-11T10:10:33+00:00"
generated_at: "2026-09-11T10:15:04.530124+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Lipocine raises ATM sales agent fee to up to 3.0% under 2024 agreement

## Summary
- On Sept 8, 2026, Lipocine and A.G.P./Alliance Global Partners agreed the Sales Agent fee under the April 26, 2024 Sales Agreement will be up to 3.0%.
- Fee is subject to adjustment by mutual consent; replaces prior fee terms under the same ATM agreement.
- No offering size, proceeds, or timeline disclosed in this filing.

## SEC filing metadata
- accession: 0001493152-26-042286
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2026-09-11T10:10:33+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315226042286/0001493152-26-042286-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315226042286/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042286
- JSON: https://secwatch.observer/filing/0001493152-26-042286.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042286.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.